
How Could a New Longevity Medicine Create $200B Per Year in Revenue? Dr. Greg Bailey and I asked top VC Alex Colville from age1
Longevity for Investors with Dr. Greg Bailey and Jess Larsen
00:00
Intro
Jess and Greg introduce the Longevity for Investors mini-series and guest Alex Colville, outlining the episode's focus on investing in longevity biotech.
Transcript
Play full episode